News for DXCM Stock

Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time. Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems Dexcom Appoints Jon Coleman as Chief Commercial Officer Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care Dexcom Appoints Renée Galá to Board of Directors Dexcom Announces Upcoming Conference Presentation Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time. Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference Dexcom Launches the First Generative AI Platform in Glucose Biosensing Alberta Government Lifts Age Restrictions on Continuous Glucose Monitors (CGM) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 CGM Dexcom and ŌURA Announce Strategic Partnership Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day Dexcom Reports Third Quarter 2024 Financial Results Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time. Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium Dexcom Announces Upcoming Conference Presentation Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available RAMQ Expands Provincial Coverage to Include Dexcom G7, Bringing the Next-Generation CGM System to More Québec Residents Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time. Dexcom Expands AID Partnership Into The Netherlands Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes Dexcom G7 Now Connects Directly to Apple Watch in the U.S. Dexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM Dexcom Announces Upcoming Conference Presentation Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes Dexcom Reports First Quarter 2024 Financial Results Dexcom Publishes Annual Sustainability Report Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD Dexcom Announces Upcoming Conference Presentation Dexcom Reports Fourth Quarter and Fiscal Year 2023 Financial Results Dexcom Launches Dexcom One+ Bringing Powerful, New Diabetes Management Technology to More People Dexcom Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call for February 8, 2024 at 4:30 p.m. Eastern Time Dexcom Secures Future in Europe, Middle East, and Africa by Breaking Ground on New Manufacturing Facility in Ireland A Powerful Alliance: Dexcom G7 Now Connects to Tandem t:slim X2 Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2023 and Initial 2024 Outlook Dexcom to Present at 42nd Annual J.P. Morgan Healthcare Conference Synchron Appoints Andy Rasdal to Board of Directors Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t:slim X2 Insulin Pump Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t:slim X2 Insulin Pump Dexcom Announces Upcoming Conference Presentation Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day Historic Victory as People With Diabetes Win Access to Life-Changing Technology, But Almost Half Don’t Understand the Benefits1-2 Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase Program Next-Generation Dexcom G7 Continuous Glucose Monitoring System Now Available in Canada Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD Dexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4:30 p.m. Eastern Time. Dexcom Canada and RxFood Corporation Partner on Industry-Leading, AI-powered Nutrition and Glucose Monitoring Solution for Diabetes Management and Personalized Therapeutic Nutrition Dexcom U Kicks off 2023 Season With Expanded Roster of Athletes With Diabetes, Building on First-of-its-Kind NIL Program Dexcom Unlocks Access to Real-Time CGM for a Further Half a Million People With Diabetes in France Dexcom G6 Strengthens Its Position as World’s Most Connected CGM System With a New Aid Offering in Germany Dexcom Announces Upcoming Conference Presentations Dexcom Appoints Rimma Driscoll to Board of Directors Dexcom Canada Achieves Great Place to Work® Certification for Second Consecutive Year Dexcom Reports Second Quarter 2023 Financial Results Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4:30 p.m. Eastern Time Dexcom G7 Receives Health Canada Approval: Next-Generation Continuous Glucose Monitoring System With Unmatched Accuracy Coming to Canadians Global Continuous Glucose Monitoring Pioneer Dexcom Reveals New Plans to Bring Sensing Technology to Millions More Dexcom Updates Long-Range Financial Targets Dexcom G6 Strengthens Its Position as World’s Most Connected CGM System Dexcom to Host Investor Day on June 23, 2023 Dexcom Announces Upcoming Conference Presentation Dexcom Showcases Accuracy, Reliability and Ease of Use of Its Dexcom G6 CGM System at the 66th Annual Meeting of the Japan Diabetes Society Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028 Dexcom rtCGM is Likely to be Cost-Saving, Study Suggests Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes Dexcom Reports First Quarter 2023 Financial Results Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB Dexcom Commends Decision to Expand CGM Medicare Coverage to Include People With Diabetes Using All Types of Insulin Dexcom Schedules First Quarter 2023 Earnings Release and Conference Call for April 27, 2023 at 4:30 p.m. Eastern Time Dexcom Publishes Annual Sustainability Report Manitoba Becomes a Provincial Trailblazer in Providing Simplified Access to Advanced Glucose Monitors DexCom Comments on SVB Relationship Dexcom Announces Upcoming Conference Presentations Dexcom Showcases Accuracy, Simplicity and Connectivity of Its CGM Portfolio at ATTD Conference as Access to CGM Expands Globally Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4:30 p.m. Eastern Time Dexcom G6 Real-Time CGM System Now Available to All Clients With Type 1 Diabetes Covered Under the Non-Insured Health Benefits Program Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook Dexcom Appoints Teri Lawver as Chief Commercial Officer Dexcom to Present at 41st Annual J.P. Morgan Healthcare Conference Dexcom Canada Partners With Green Shield and The Health Depot to Offer Plan Members a Comprehensive Digital Diabetes Care Experience Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S. Truckers’ Health Adaptative Technology (T.H.A.T.) Study Evaluates the Impact of Digital Virtual Models of Care on the Health and Wellbeing of Professional Truck Drivers Dexcom Announces Upcoming Conference Presentation Dexcom Invites the Diabetes Community to #seediabetes This November and Share Their Diabetes Story With Custom Continuous Glucose Monitor (CGM) Patches Dexcom Partners With Warriors and Nonprofits to Artfully Advocate for Access to Diabetes Care Dexcom Reports Third Quarter 2022 Financial Results Dexcom, Adam Schefter Announce Dexcom U, the First NIL Program for College Athletes With Diabetes Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time. Dexcom Announces Upcoming Conference Presentations DexCom Promotes Jake Leach to Chief Operating Officer Dexcom Announces Upcoming Conference Presentation Dexcom ONE real-time Continuous Glucose Monitoring (rt-CGM) System available on prescription in the UK, improving access to rt-CGM for people with diabetes Dexcom Reports Second Quarter 2022 Financial Results Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish Dexcom Canada Achieves Great Place to Work® Certification Dexcom Schedules Second Quarter 2022 Earnings Release and Conference Call for July 28, 2022 at 4:30 p.m. Eastern Time. Come Chill at Dexcom’s ‘No Pricks Parlour’ With Ed Gamble for Diabetes Awareness Week, Celebrating You! Dexcom to Showcase Expanded CGM Portfolio and Industry-leading Connectivity at 82nd Scientific Sessions of the American Diabetes Association Prince Edward Island Becomes a National Leader in Providing Coverage for Dexcom G6 Continuous Glucose Monitoring System for Canadians With Diabetes Dexcom Issues Statement on Recent Market Speculation Dexcom Announces Upcoming Conference Presentation Dexcom Announces Upcoming Conference Presentations Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time Dexcom Reports First Quarter 2022 Financial Results DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People With Diabetes Dexcom Publishes Annual Sustainability Report Dexcom Announces Dexcom ONE, the Newest Real-Time Continuous Glucose Monitoring System, to Its Range of Scan-Free and Fingerprick†-Free Devices Dexcom Schedules First Quarter 2022 Earnings Release and Conference Call for April 28, 2022 at 4:30 p.m. Eastern Time Dexcom Announces Four-for-One Forward Stock Split Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management Ontario Announces Public Coverage for the Dexcom G6 Continuous Glucose Monitoring System under the Assistive Devices Program FDA Grants Breakthrough Device Designation for Dexcom Hospital CGM System Dexcom Announces Upcoming Virtual Conference Presentations Dexcom Reports Fourth Quarter and Fiscal Year 2021 Financial Results Dexcom G6 Continuous Glucose Monitoring System Now Covered in Alberta for Children and Youth Living With Diabetes Dexcom Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for February 10, 2022 at 4:30 p.m. Eastern Time. Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter 2021 and Summary Data from the Dexcom G7 U.S. Pivotal Trial Dexcom to Present at 40th Annual J.P. Morgan Healthcare Conference Dexcom Announces Upcoming Conference Presentation Dexcom, Nick Jonas, Patti LaBelle and The Global Movement for Time in Range Invite the World to #SeeDiabetes This November Dexcom Reports Third Quarter 2021 Financial Results Dexcom Expands Time in Range Initiative with Nick Jonas to Help Improve the Lives of People with Diabetes in the UK Dexcom Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021 at 4:30 p.m. Eastern Time Dexcom G6 Continuous Glucose Monitoring System Now Covered in Manitoba for Young People With Type 1 Diabetes Non-insured Health Benefits Program Now Covers Dexcom G6 Continuous Glucose Monitoring System for Children and Adolescents on Intensive Insulin Therapy Dexcom Announces Upcoming Virtual Conference Presentations Dexcom Reports Second Quarter 2021 Financial Results FDA Clears Dexcom Real-Time APIs for Third-Party Apps and Devices Dexcom Schedules Second Quarter 2021 Earnings Release and Conference Call for July 29, 2021 at 4:30 p.m. Eastern Time Dexcom CGM Plays Starring Role at 81st Scientific Sessions of the American Diabetes Association DexCom, Nick Jonas and Leading Diabetes Nonprofits Launch Initiative to Help Improve the Lives of People With Diabetes Endurance Athlete Sébastien Sasseville to Ride Across Canada in Support of JDRF’s Access For All Campaign British Columbia First Province to Cover Dexcom G6 Continuous Glucose Monitoring System for People With Type 1 and Type 2 Diabetes on Intensive Insulin Therapy Dexcom Looks to the Future of Continuous Glucose Monitoring Dexcom Announces Upcoming Conference Presentation Dexcom Reports First Quarter 2021 Financial Results Dexcom Schedules First Quarter 2021 Earnings Release and Conference Call for April 29, 2021 at 4:30 p.m. Eastern Time Dexcom Promotes Jereme Sylvain to Chief Financial Officer Dexcom Announces Upcoming Virtual Conference Presentations Dexcom Launches Inaugural Venture Capital Fund Dexcom Reports Fourth Quarter and Fiscal Year 2020 Financial Results Dexcom and Nick Jonas Unveil First-Ever Super Bowl Commercial, Calling for Better Care for People With Diabetes Dexcom Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for February 11, 2021 at 4:30 p.m. Eastern Time Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2020 and Provides Initial 2021 Outlook Dexcom to Present at 39th Annual J.P. Morgan Healthcare Conference Dexcom Announces Upcoming Virtual Conference Presentations Dexcom to Host Investor Day on December 9, 2020 Dexcom to Host Investor Day on December 9, 2020 Dexcom Reports Third Quarter 2020 Financial Results Dexcom Announces Retirement of Rick Doubleday and Pre-Announcement of Third Quarter 2020 Revenue Dexcom Appoints Kyle Malady to Board of Directors Dexcom Schedules Third Quarter 2020 Earnings Release and Conference Call for October 27, 2020 at 4:30 p.m. Eastern Time.